Bio-Medical Applications Of Alabama, Inc in Birmingham, Alabama - Dialysis Center

Bio-Medical Applications Of Alabama, Inc is a medicare approved dialysis facility center in Birmingham, Alabama and it has 10 dialysis stations. It is located in Jefferson county at 2024 4th Ave South, Suite 100, Birmingham, AL, 35233. You can reach out to the office of Bio-Medical Applications Of Alabama, Inc at (205) 321-5844. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Alabama, Inc has the following ownership type - Profit. It was first certified by medicare in September, 2016. The medicare id for this facility is 012687 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Alabama, Inc
Location	2024 4th Ave South, Suite 100, Birmingham, Alabama
No. of Dialysis Stations	10
Medicare ID	012687
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Alabama, Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1225411739
Organization Name	Fresenius Medical Care Birmingham Metro
Doing Business As	Bio-medical Applications Of Alabama, Inc.
Address	2024 4th Ave S Birmingham, Alabama, 35233
Phone Number	(205) 802-1676

Dialysis patients with Hemoglobin data

6

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	43
  Adult patient months included in Kt/V greater than or equal to 1.2	124
  Percentage of adult patients getting regular hemodialysis at the center	98
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Alabama, Inc with elevated calcium levels.

Patients with hypercalcemia	43
Hypercalcemia patient months	124
Patients with Serumphosphor	45
Patients with Serumphosphor less than 3.5 mg/dL	10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	33
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	20
Patients with Serumphosphor from 5.6 to 7 mg/dL	22
Patients with Serumphosphor greater than 7 mg/dL	15

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	63
Patient months included in arterial venous fistula and catheter summaries	180
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	55
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	6

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	1
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit